Two Sigma Advisers’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-189,156
| Closed | -$10.4M | – | 2843 |
|
|
2022
Q2 | $10.4M | Sell |
189,156
-67,400
| -26% | -$3.71M | 0.03% | 493 |
|
|
2022
Q1 | $8.22M | Buy |
256,556
+194,800
| +315% | +$6.24M | 0.02% | 597 |
|
|
2021
Q4 | $1.34M | Buy |
61,756
+19,100
| +45% | +$415K | ﹤0.01% | 1396 |
|
|
2021
Q3 | $935K | Buy |
+42,656
| New | +$935K | ﹤0.01% | 1647 |
|
|
2020
Q1 | – | Sell |
-3,693
| Closed | -$51K | – | 2612 |
|
|
2019
Q4 | $51K | Sell |
3,693
-277
| -7% | -$3.83K | ﹤0.01% | 2292 |
|
|
2019
Q3 | $62K | Buy |
3,970
+2,182
| +122% | +$34.1K | ﹤0.01% | 2143 |
|
|
2019
Q2 | $40K | Buy |
1,788
+890
| +99% | +$19.9K | ﹤0.01% | 2263 |
|
|
2019
Q1 | $61K | Buy |
898
+310
| +53% | +$21.1K | ﹤0.01% | 2223 |
|
|
2018
Q4 | $31K | Sell |
588
-447
| -43% | -$23.6K | ﹤0.01% | 2303 |
|
|
2018
Q3 | $70K | Buy |
1,035
+20
| +2% | +$1.35K | ﹤0.01% | 2163 |
|
|
2018
Q2 | $120K | Buy |
+1,015
| New | +$120K | ﹤0.01% | 2259 |
|
|
2018
Q1 | – | Sell |
-290
| Closed | -$43K | – | 2460 |
|
|
2017
Q4 | $43K | Buy |
+290
| New | +$43K | ﹤0.01% | 2201 |
|